CN111440087A - Production process of oxygen- [2- [2- [2- (2-methoxyethoxy) ethoxy ] ethyl ] hydroxylamine - Google Patents

Production process of oxygen- [2- [2- [2- (2-methoxyethoxy) ethoxy ] ethyl ] hydroxylamine Download PDF

Info

Publication number
CN111440087A
CN111440087A CN202010267540.1A CN202010267540A CN111440087A CN 111440087 A CN111440087 A CN 111440087A CN 202010267540 A CN202010267540 A CN 202010267540A CN 111440087 A CN111440087 A CN 111440087A
Authority
CN
China
Prior art keywords
ethoxy
hydroxylamine
methoxyethoxy
ethyl
dichloromethane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010267540.1A
Other languages
Chinese (zh)
Inventor
陈建芳
刘贞兴
宋泽华
李小芩
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing Youfu Pharmaceutical Technology Co ltd
Original Assignee
Nanjing Youfu Pharmaceutical Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing Youfu Pharmaceutical Technology Co ltd filed Critical Nanjing Youfu Pharmaceutical Technology Co ltd
Priority to CN202010267540.1A priority Critical patent/CN111440087A/en
Publication of CN111440087A publication Critical patent/CN111440087A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C239/00Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof
    • C07C239/08Hydroxylamino compounds or their ethers or esters
    • C07C239/20Hydroxylamino compounds or their ethers or esters having oxygen atoms of hydroxylamino groups etherified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide

Abstract

The invention discloses an oxy- [2- [2- [2- (2-methoxyethoxy) ethoxy group]Ethoxy radical]Ethyl radical]The production process of hydroxylamine is characterized by that it uses tetraethylene glycol monomethyl ether as starting material, makes it produce Mitsunobu reaction with NHPI to produce compound 1, then makes it produce NH3‑CH3And obtaining the target compound 2 under the action of the OH solution. By establishing strict internal control standards for the starting raw materials and intermediates and strictly controlling the parameters of key process steps, qualified products can be stably prepared in multiple batches.

Description

Production process of oxygen- [2- [2- [2- (2-methoxyethoxy) ethoxy ] ethyl ] hydroxylamine
Technical Field
The invention relates to a production process of oxygen- [2- [2- [2- (2-methoxyethoxy) ethoxy ] ethyl ] hydroxylamine.
Background
Oxy- [2- [2- [2- (2-methoxyethoxy) ethoxy]Ethoxy radical]Ethyl radical]The English chemical name of hydroxylamine is O- [2- [2- (2-methoxy) ethoxy]ethoxy]ethyl]Hydroxylamine, Chemical Abstracts (CAS) number 1355318-41-0, having the structural formula:
Figure BDA0002441881930000011
no preparation method of the compound is found in the literature at present.
Disclosure of Invention
The present invention provides a process for the production of oxygen- [2- [2- [2- (2-methoxyethoxy) ethoxy ] ethyl ] hydroxylamine.
The invention provides the following technical scheme:
the production process of oxygen- [2- [2- [2- (2-methoxyethoxy) ethoxy ] ethyl ] hydroxylamine has the following synthetic route:
Figure BDA0002441881930000012
wherein NHPI is N-hydroxyphthalimide DIAD is diisopropyl azodicarboxylate; PPh3Is triphenylphosphine; DCM is dichloromethane;
s1, carrying out Mitsunobu reaction on tetraethylene glycol monomethyl ether serving as a raw material and NHPI to generate a compound 1;
s2, Compound 1 and NH3-CH3And obtaining the target compound 2 under the action of the OH solution.
Further, tetraethylene glycol monomethyl ether, NHPI, PPh3And DIAD in a 1:1.2 molar ratio: 1.2: 2.4. Dissolving tetraethylene glycol monomethyl ether with dichloromethane, cooling to 0 deg.C, and adding PPh3NHPI and DIAD, and then reacted at room temperature for 12 h.
Further, the molar ratio of the intermediate 1 to the ammonia-methanol solution (7M) in S2 is 1: 145, the intermediate 1 is added with the ammonia-methanol solution, stirred and dissolved, the reaction is heated to 40 ℃, the reaction is carried out for 12h, then the volatile matter is removed by vacuum concentration after the reaction, the remainder is dissolved by dichloromethane and filtered, the filter cake is washed twice by dichloromethane, the filtrate is combined, 1.2M hydrochloric acid is slowly dripped into the filtrate to adjust the pH value of the solution to about 4.0, the solution is kept stand and layered, the water phase is separated and washed twice by dichloromethane, then saturated sodium carbonate solution is slowly dripped into the water phase to adjust the pH value of the solution to 9.0, then dichloromethane (150M L) is used for extraction for three times, the organic phase is combined, dried by anhydrous magnesium sulfate, filtered and concentrated under vacuum to obtain the target compound.
The invention discloses an oxy- [2- [2- [2- (2-methoxyethoxy) ethoxy group]Ethoxy radical]Ethyl radical]The production process of hydroxylamine uses tetraethylene glycol monomethyl ether as initial material, and makes it and NHPI produce Mitsunobu reaction to produce compound 1, then makes it undergo the process of NH3-CH3And obtaining the target compound 2 under the action of the OH solution. The key process step parameters are strictly controlled by establishing strict internal control standards for the starting raw materials and the intermediatesAnd qualified products can be stably prepared in multiple batches.
Detailed Description
The following description of the preferred embodiments of the present invention is provided for the purpose of illustration and description, and is in no way intended to limit the invention.
Examples
The production process of oxygen- [2- [2- [2- (2-methoxyethoxy) ethoxy ] ethyl ] hydroxylamine has the following synthetic route:
Figure BDA0002441881930000031
s1 Synthesis procedure of intermediate 1
Figure BDA0002441881930000032
Figure DEST_PATH_IMAGE001
Weighing tetraethylene glycol monomethyl ether (10.0g,48.0mmol,1.0equiv.) in a 2L round-bottom flask, adding dichloromethane (1000m L), stirring to dissolve, cooling the reaction to 0 ℃, and respectively adding PPh3(15.1g, 57.6mmol,1.2equiv.), NHPI (9.5g,57.6mmol,1.2equiv.), and DIAD (22.4m L, 115.2mmol,2.4equiv.), after addition, the reaction was left at room temperature for 12 h.
The volatiles were removed by concentration under reduced pressure and dried under vacuum directly to the next step.
S2 Synthesis Process of target product 2
Figure BDA0002441881930000034
Figure BDA0002441881930000035
Figure BDA0002441881930000041
To the crude product obtained above was added ammonia-methanol solution (7M in CH)3OH, 1L), stirring to dissolve, heating the reaction to 40 ℃, and reacting for 12 hours.
Concentrating under reduced pressure to remove volatile substances, dissolving the residues with dichloromethane (200M L), filtering, washing the filter cake twice with dichloromethane (50M L), combining the filtrates, slowly dropwise adding 1.2M hydrochloric acid into the filtrate to adjust the pH of the solution to about 4.0, standing for layering, separating an aqueous phase, washing the aqueous phase twice with dichloromethane (100M L), then slowly dropwise adding a saturated sodium carbonate solution into the aqueous phase to adjust the pH of the solution to about 9.0, extracting with dichloromethane (150M L) for three times, combining the organic phases, drying with anhydrous magnesium sulfate, filtering, and concentrating under reduced pressure to obtain the target compound 2 (light yellow oily liquid) with qualified purity.
The mass of the obtained compound 2 was weighed to 6.9g, and the yield was 65%.
Finally, it should be noted that: although the present invention has been described in detail with reference to the foregoing embodiments, it will be apparent to those skilled in the art that changes may be made in the embodiments and/or equivalents thereof without departing from the spirit and scope of the invention. Any modification, equivalent replacement, or improvement made within the spirit and principle of the present invention should be included in the protection scope of the present invention.

Claims (6)

1. The production process of the oxygen- [2- [2- [2- (2-methoxyethoxy) ethoxy ] ethyl ] hydroxylamine is characterized in that the synthetic route is as follows:
Figure FDA0002441881920000011
wherein NHPI is N-hydroxyphthalimide DIAD is diisopropyl azodicarboxylate; PPh3Is triphenylphosphine; DCM is dichloromethane;
s1, carrying out Mitsunobu reaction on tetraethylene glycol monomethyl ether serving as a raw material and NHPI to generate a compound 1;
s2, Compound 1 and NH3-CH3And obtaining the target compound 2 under the action of the OH solution.
2. Oxy- [2- [2- [2- (2-methoxyethoxy) ethoxy ] as claimed in claim 1]Ethoxy radical]Ethyl radical]The production process of hydroxylamine is characterized by that it uses tetraethylene glycol monomethyl ether, NHPI and PPh3And DIAD in a 1:1.2 molar ratio: 1.2: 2.4.
3. oxy- [2- [2- [2- (2-methoxyethoxy) ethoxy ] as claimed in claim 2]Ethoxy radical]Ethyl radical]The production process of hydroxylamine is characterized by that the tetraglycol monomethyl ether is dissolved by adopting dichloromethane, then cooled to 0 deg.C, then respectively added into PPh3NHPI and DIAD, and then reacted at room temperature for 12 h.
4. A process for the production of oxo- [2- [2- [2- (2-methoxyethoxy) ethoxy ] ethyl ] hydroxylamine as claimed in claim 1 wherein the molar ratio of intermediate 1 to ammonia-methanol solution (7M) in S2 is 1: 145.
5. the process for producing oxy- [2- [2- [2- (2-methoxyethoxy) ethoxy ] ethyl ] hydroxylamine as claimed in claim 1, wherein the intermediate 1 is dissolved in ammonia-methanol solution in S2 by stirring, and the reaction is heated to 40 ℃ and reacted for 12 hours.
6. The process for producing oxy- [2- [2- [2- (2-methoxyethoxy) ethoxy ] ethyl ] hydroxylamine as claimed in claim 5, wherein the reaction is followed by concentrating under reduced pressure to remove volatiles, dissolving the residue in dichloromethane, suction filtration, washing the filter cake twice with dichloromethane, combining the filtrates, adding hydrochloric acid slowly dropwise to the filtrate to adjust the pH of the solution to about 4.0, standing for layering, separating the aqueous phase, washing the aqueous phase twice with dichloromethane, then adding saturated sodium carbonate solution slowly dropwise to the aqueous phase to adjust the pH of the solution to 9.0, extracting three times with dichloromethane (150m L), combining the organic phases, drying over anhydrous magnesium sulfate, suction filtration, and concentrating under reduced pressure to obtain the objective compound 2 of acceptable purity.
CN202010267540.1A 2020-04-08 2020-04-08 Production process of oxygen- [2- [2- [2- (2-methoxyethoxy) ethoxy ] ethyl ] hydroxylamine Pending CN111440087A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010267540.1A CN111440087A (en) 2020-04-08 2020-04-08 Production process of oxygen- [2- [2- [2- (2-methoxyethoxy) ethoxy ] ethyl ] hydroxylamine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010267540.1A CN111440087A (en) 2020-04-08 2020-04-08 Production process of oxygen- [2- [2- [2- (2-methoxyethoxy) ethoxy ] ethyl ] hydroxylamine

Publications (1)

Publication Number Publication Date
CN111440087A true CN111440087A (en) 2020-07-24

Family

ID=71650067

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010267540.1A Pending CN111440087A (en) 2020-04-08 2020-04-08 Production process of oxygen- [2- [2- [2- (2-methoxyethoxy) ethoxy ] ethyl ] hydroxylamine

Country Status (1)

Country Link
CN (1) CN111440087A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008083346A1 (en) * 2006-12-28 2008-07-10 Ambrx, Inc. Phenazine and quinoxaline substituted amino acids and polypeptides

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008083346A1 (en) * 2006-12-28 2008-07-10 Ambrx, Inc. Phenazine and quinoxaline substituted amino acids and polypeptides

Similar Documents

Publication Publication Date Title
KR20130129180A (en) Process for preparing aminobenzoylbenzofuran derivatives
JP5016575B2 (en) A novel synthesis of strontium ranelate and its hydrates
KR20170029506A (en) Process for the preparation of 4-alkoxy-3-hydroxypicolinic acids
CN111116591A (en) Method for preparing sildenafil citrate
CN112300071B (en) Synthetic method of high-purity chloroquine phosphate
DK2170829T3 (en) Process for the preparation of a toluidinforbindelse
CN111440087A (en) Production process of oxygen- [2- [2- [2- (2-methoxyethoxy) ethoxy ] ethyl ] hydroxylamine
US20120022282A1 (en) Process for the preparation of 2,4,6-octatriene-1-oic acid and 2,4,6-octatriene-1-ol
RU2263110C2 (en) Method for preparing derivatives of quinoline
CN113072514B (en) Preparation method of Xuanjinning and intermediate thereof
CN111269149B (en) Production process of 5- (3,3-dimethylguanidino) -2-oxopentanoic acid
CN109608497B (en) Preparation method of fosfomycin trometamol
CN110172076B (en) Quinoline derivative containing exocyclic double bond and preparation method thereof
CN109232222B (en) Preparation method of (E) -octyl-4-ene-1, 8-diacid
JPH04290877A (en) Process for producing symmetric 2,2'-methylenebisbenzotriazolyl phenols
KR100881890B1 (en) Process for preparation of Sarpogrelate HCl salt
CN113461618A (en) Preparation method of lopinavir
JP4700777B2 (en) Improved process for the preparation of 4-amino-1,2,4-triazolin-5-one
CN110294768B (en) Method for synthesizing pinoxaden through 2, 6-diethyl-4-methyl phenylmalonate
US5696283A (en) Preparation of methyl isoproylideneaminooxyacetoxyacetate
KR100805198B1 (en) New preparation method of 10-(2,5-dihydroxyphenyl-9,10-dihydro-9-oxa-phosphaphenanthrene-10-oxide
CN110734398A (en) process for preparing 2-chloronicotinic acid
CN115490726B (en) Preparation method of diphenyl phosphine oxide hydrogen
CN113527137B (en) Preparation method of trifloxystrobin characteristic impurities
JPH0136818B2 (en)

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20200724